|
🐜
|
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.
11 auth.
R. V. van Kimmenade,
J. Januzzi,
P. Ellinor,
U. Sharma,
J. Bakker,
A. Low,
...
Abelardo Martinez,
H. Crijns,
C. Macrae,
P. Menheere,
Y. Pinto
|
9 |
2006 |
9
🐜
|
|
🐜
|
Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects.
10 auth.
R. V. van Kimmenade,
J. Januzzi,
J. Bakker,
A. Houben,
R. Rennenberg,
A. Kroon,
...
H. Crijns,
M. V. van Dieijen-Visser,
P. D. de Leeuw,
Y. Pinto
|
7 |
2009 |
7
🐜
|
|
🐜
|
Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy.
35 auth.
J. Halter,
W. Michael,
M. Schüpbach,
M. Schüpbach,
H. Mandel,
C. Casali,
K. Orchard,
M. Collin,
D. Valcárcel,
A. Rovelli,
M. Filosto,
M. Dotti,
G. Marotta,
G. Pintos,
P. Barba,
...
A. Accarino,
C. Ferrá,
I. Illa,
Y. Beguin,
J. Bakker,
J. Boelens,
I. Coo,
K. Fay,
C. Sue,
D. Nachbaur,
H. Zoller,
C. Sobreira,
B. Simões,
S. Hammans,
D. Savage,
R. Martí,
P. Chinnery,
R. Elhasid,
A. Gratwohl,
M. Hirano
|
7 |
2015 |
7
🐜
|
|
🐜
|
FRI0330 Rituximab therapy in sle: early retreatment is associated with lower disease activity and a reduction in corticosteroid use
13 auth.
T. Kraaij,
S. Kamerling,
E. D. de Rooij,
P. V. van Daele,
O. Bredewold,
J. Bakker,
I. Bajema,
H. Scherer,
R. Toes,
T. Huizinga,
...
T. Rabelink,
C. van Kooten,
Y. Teng
|
6 |
2018 |
6
🐜
|
|
🐜
|
Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors
10 auth.
E. C. de Moel,
E. Rozeman,
E. Kapiteijn,
E. Verdegaal,
A. Grummels,
J. Bakker,
...
T. Huizinga,
J. Haanen,
R. Toes,
D. van der Woude
|
6 |
2018 |
6
🐜
|
|
🐢
|
Pharmacogenetic significance of inosine triphosphatase.
J. Bierau,
M. Lindhout,
J. Bakker
|
6 |
2007 |
6
🐢
|
|
🐜
|
Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA.
13 auth.
T. Kraaij,
S. Kamerling,
L. S. van Dam,
J. Bakker,
I. Bajema,
T. Page,
F. Brunini,
C. Pusey,
R. Toes,
H. Scherer,
...
T. Rabelink,
C. van Kooten,
Y. Teng
|
6 |
2018 |
6
🐜
|
|
🐜
|
Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
14 auth.
L. Gilissen,
D. Wong,
L. Engels,
J. Bierau,
J. Bakker,
A. Paulussen,
M. Romberg-Camps,
A. Stronkhorst,
P. Bus,
L. Bos,
...
P. Hooymans,
R. Stockbrügger,
C. Neef,
A. Masclee
|
6 |
2012 |
6
🐜
|
|
🐜
|
Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies
11 auth.
I. Markusse,
J. Meijs,
B. de Boer,
J. Bakker,
H. Pascal C. Schippers,
A. Schouffoer,
...
N. Ajmone Marsan,
L. Kroft,
M. Ninaber,
T. Huizinga,
J. D. de Vries-Bouwstra
|
6 |
2016 |
6
🐜
|
|
🐜
|
Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Compared to Systemic Lupus Erythematosus
8 auth.
Laura S. Dam,
T. Kraaij,
S. Kamerling,
J. Bakker,
U. Scherer,
T. Rabelink,
...
C. Kooten,
Y. Teng
|
5 |
2019 |
5
🐜
|
